MindRank doses first patient in phase III clinical trial of AI-designed oral GLP-1 receptor agonist, MDR-001: Shanghai Saturday, February 28, 2026, 18:00 Hrs [IST] MindRank, a cli ...

Core Solutions introduces DSP Assist mobile app for compliant IDD service delivery: King of Prussia, Pennsylvania Saturday, February 28, 2026, 17:00 Hrs [IST] Core Solutions (Core ...

CDSCO introduces SHRESTH index to improve performance of state drug regulatory authorities: Shardul Nautiyal, Mumbai Saturday ...

YD Bio partners with YC Biotech to establish Taiwan-US dual-core regulatory platform: Taipei, Taiwan Saturday, February 28, 2026, 15:00 Hrs [IST] YD Bio Limited, a biotechnology c ...

Intelligent Bio Solutions ships Intelligent Fingerprinting Drug Screening Readers with Syrma Johari MedTech: New York Saturday, February 28, 2026, 16:00 Hrs [IST] Intelligent Bio ...

ViiV Healthcare presents data for two investigational HIV treatment therapies with potential for twice-yearly dosing: London Saturday, February 28, 2026, 13:00 Hrs [IST] ViiV Heal ...

CollPlant Biotechnologies’ photocurable dermal filler technology receives Korean Patent: Rehovot, Israel Saturday, February 28, 2026, 14:00 Hrs [IST] CollPlant Biotechnologies, ...

US FDA accepts Viatris’ sNDA of MR-141 to review for treatment of presbyopia: Pittsburgh Saturday, February 28, 2026, 12:00 Hrs [IST] Viatris Inc, US-headquartered global health ...

Our Bureau, Mumbai Saturday, February 28, 2026, 09:00 Hrs [IST] ...

Quotient Sciences extends commercial manufacturing partnership with Ipsen for an ultra-rare disease treatment: Philadelphia, Pennsylvania Saturday, February 28, 2026, 10:00 Hrs [I ...

Ultima Genomics, Hamilton partner to enable improved lab operations to drive sequencing at scale: Fremont, California Saturday, February 28, 2026, 11:00 Hrs [IST] Ultima Genomics, ...

India’s neurodevelopment care sees decisive shift toward structured, evidence-based informed pathways: Nitin Bindlish: Nandita Vijayasimha, Bengaluru Saturday, February 28, 2026 ...